PNEUMOCOCCAL VACCINATION (PNEUMONIA)

Older adults are at greatest risk of serious illness and death.

PNEUMOVAX 23 can help protect against infection by 23 types of pneumococcal bacteria. These 23 types include those that are most common and most often cause serious disease (pneumonia, bacteraemia, and meningitis).

Streptococcus pneumoniae infections are a major cause of illness and death worldwide. Invasive pneumococcal disease (IPD) is most common in the very young, the elderly and persons at high risk due to underlying medical conditions or lifestyle factors. Vaccine efficacy against IPD is estimated to be 50% to 80% among the elderly and in high-risk groups.

Who should get the vaccine:

• Adults 65 years of age and older regardless of risk factors or previous pneumococcal vaccination.

• Residents of Care Facilities.

• Individuals 2 years of age and older with:

o Anatomic or non-functional spleen

o Sickle cell disease

o Immunosuppression related to disease or therapy

o Congenital immunodeficiency states

o Chronic heart or lung disease (except asthma, unless management involves ongoing high dose oral corticosteroid treatment)

o Chronic kidney or liver disease

o Solid organ, stem cell or islet cell transplant

o Diabetes

o Alcoholism

o Cystic fibrosis

o Chronic CSF leak

o Cochlear implant

o Homelessness C and/or illicit drug use

o Chronic neurological conditions that may impair clearance of oral secretions

 

BOOSTER DOSES

A one time only revaccination should be offered 5 years after the initial immunization to those who have:

o Anatomic or non-functional spleen
o Sickle cell disease
o Immunosuppression related to disease or therapy
o Congenital immunodeficiency states
o Chronic heart or lung disease (except asthma, unless management involves ongoing high dose oral corticosteroid treatment)
o Chronic kidney or liver disease
o Solid organ, stem cell or islet cell transplant (candidate or recipient)

 

VACCINATIONS FOR PNEUMONIA

Pneumovax 23 vs. Prevnar 13

PNEUMOVAX 23

 Pneumovax 23 protects against 23 types of pneumococcal bacteria

Pneumovax 23 is the vaccine used in adults. It does not work in infants and children under 2 years old.
Most adults do not need a pneumococcal vaccine until they reach the age of 65 unless they meet the criteria listed above before the age of 65. Once a person turns 65 years old, the CDC recommends Pneumovax 23. Studies show that one dose of Pneumovax 23 protects 50% to 85% of healthy adults against invasive pneumococcal disease.

PREVNAR 13

Prevnar 13 protects against 13 types of pneumococcal bacteria

Prevnar 13 was developed for infants and children. The CDC recommends that all infants and children younger than 2 years of age get Prevnar 13. Prevnar 13 involves a series of four doses of the vaccine given during their childhood shots.

In some cases, the CDC recommends that adults get Prevnar 13 in addition to Pneumovax 23. If a person has any of the following conditions, they are considered at high risk for a serious pneumococcal infection, and need both vaccines:​

  • A spleen that doesn’t work well or no spleen

  • Sickle cell disease or other inherited blood disorder

  • HIV infection

  • Cancer of the blood (leukemia, lymphoma, Hodgkin disease, multiple myeloma)

  • Metastatic cancer (cancer that has spread beyond the original location)

  • Organ/islet cell transplantation

  • Anyone who takes medications that lower your immune system (including long-term steroid use and radiation therapy)


Unimmunized individuals should receive PCV13 vaccine first followed by PPV23 at least 8 weeks later. If PPV23 has already been administered, PCV13 should be administered at least one year later

 

THE SPREAD IS UNPREDICTABLE

Let's Get You Covered

Pneumonia, mainly caused by the bacterium Streptococcus pneumoniae, is transmitted by direct oral contact or indirect contact with respiratory secretions or droplets of infected persons. A person can still transmit the infection usually until 24 hours following appropriate antibiotic treatment. 

 

©2020 by Columbia Street Pharmacy.